Literature DB >> 8071116

Dual function of macrophage galactose/N-acetylgalactosamine-specific lectins: glycoprotein uptake and tumoricidal cellular recognition.

K Kawakami1, K Yamamoto, S Toyoshima, T Osawa, T Irimura.   

Abstract

We investigated whether the interaction of peritoneal macrophages with extracellular ligands is mediated by C-type lectins specific for galactose and N-acetylgalactosamine. The carbohydrate-binding domain of mouse galactose/N-acetylgalactosamine-specific lectin was prepared in a recombinant form. The purified recombinant lectins were tested for competitive inhibition against glycoprotein uptake and against tumoricidal effect. Thioglycolate-elicited macrophages internalized galactosylated bovine serum albumin in vitro. The internalization was blocked by recombinant macrophage lectins. Activated macrophages obtained after intraperitoneal injection of a nonspecific immune potentiator, OK432, did not internalize galactosylated bovine serum albumin. These cells elicited a cytotoxic effect against P815 murine mastocytoma cells, and the effect was blocked by recombinant macrophage lectins. These results indicated that galactose/N-acetylgalactosamine-specific C-type lectins expressed on the surface of inflammatory macrophages and on activated tumoricidal macrophages mediate two distinct functions, i.e. glycoprotein uptake and tumoricidal effector mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071116      PMCID: PMC5919541          DOI: 10.1111/j.1349-7006.1994.tb02423.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  29 in total

1.  Molecular cloning and expression of cDNA encoding a galactose/N-acetylgalactosamine-specific lectin on mouse tumoricidal macrophages.

Authors:  M Sato; K Kawakami; T Osawa; S Toyoshima
Journal:  J Biochem       Date:  1992-03       Impact factor: 3.387

2.  New structural characteristic of the large glycopeptides from transformed cells.

Authors:  S I Ogata; T Muramatsu; A Kobata
Journal:  Nature       Date:  1976-02-19       Impact factor: 49.962

3.  Molecular cloning and sequence analysis of cDNA encoding the macrophage lectin specific for galactose and N-acetylgalactosamine.

Authors:  M Ii; H Kurata; N Itoh; I Yamashina; T Kawasaki
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

Review 4.  Two distinct classes of carbohydrate-recognition domains in animal lectins.

Authors:  K Drickamer
Journal:  J Biol Chem       Date:  1988-07-15       Impact factor: 5.157

Review 5.  Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behavior.

Authors:  L Warren; C A Buck; G P Tuszynski
Journal:  Biochim Biophys Acta       Date:  1978-09-18

6.  A potential role for the extracellular matrix glycoprotein laminin in macrophage-tumor-cell interactions.

Authors:  T K Huard; J L Baney; J F Wood; M S Wicha
Journal:  Int J Cancer       Date:  1985-10-15       Impact factor: 7.396

7.  Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells.

Authors:  I Eggens; B Fenderson; T Toyokuni; B Dean; M Stroud; S Hakomori
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

8.  Insulin-like growth factor-II (IGF-II) inhibits both the cellular uptake of beta-galactosidase and the binding of beta-galactosidase to purified IGF-II/mannose 6-phosphate receptor.

Authors:  W Kiess; C L Thomas; L A Greenstein; L Lee; M M Sklar; M M Rechler; G G Sahagian; S P Nissley
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

9.  Purification and characterization of a lectin-like molecule specific for galactose/N-acetyl-galactosamine from tumoricidal macrophages.

Authors:  S Oda; M Sato; S Toyoshima; T Osawa
Journal:  J Biochem       Date:  1988-10       Impact factor: 3.387

10.  Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages.

Authors:  P R Crocker; S Kelm; C Dubois; B Martin; A S McWilliam; D M Shotton; J C Paulson; S Gordon
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  6 in total

1.  Generation of mice deficient for macrophage galactose- and N-acetylgalactosamine-specific lectin: limited role in lymphoid and erythroid homeostasis and evidence for multiple lectins.

Authors:  Thandi M Onami; Meei-Yun Lin; Dawne M Page; Shirley A Reynolds; Carol D Katayama; Jamey D Marth; Tatsuro Irimura; Ajit Varki; Nissi Varki; Stephen M Hedrick
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

2.  Carbohydrate binding mechanism of the macrophage galactose-type C-type lectin 1 revealed by saturation transfer experiments.

Authors:  Masayoshi Sakakura; Sarawut Oo-Puthinan; Chifumi Moriyama; Tomomi Kimura; Jun Moriya; Tatsuro Irimura; Ichio Shimada
Journal:  J Biol Chem       Date:  2008-09-12       Impact factor: 5.157

3.  Restricted expression of galactose/N-acetylgalactosamine-specific macrophage C-type lectin to connective tissue and to metastatic lesions in mouse lung.

Authors:  Y Imai; Y Akimoto; S Mizuochi; T Kimura; H Hirano; T Irimura
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

4.  Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.

Authors:  Soraya Zorro Manrique; Ana L Dominguez; Noweeda Mirza; Christopher D Spencer; Judy M Bradley; James H Finke; James J Lee; Larry R Pease; Sandra J Gendler; Peter A Cohen
Journal:  Oncotarget       Date:  2016-07-12

5.  Isolation and Assessment of a Highly-Active Anti-Inflammatory Exopolysaccharide from Mycelial Fermentation of a Medicinal Fungus Cs-HK1.

Authors:  Long-Qing Li; Ang-Xin Song; Wing-Tak Wong; Jian-Yong Wu
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

6.  CD301b+ Macrophages Are Essential for Effective Skin Wound Healing.

Authors:  Brett Shook; Eric Xiao; Yosuke Kumamoto; Akiko Iwasaki; Valerie Horsley
Journal:  J Invest Dermatol       Date:  2016-06-07       Impact factor: 7.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.